Telix Pharmaceuticals Limited
TLX
$17.60
$0.301.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 423.29% | 519.33% | -9.56% | 2.58% | 6.25% |
| Total Receivables | 88.80% | 123.45% | 38.78% | -- | 56.99% |
| Inventory | 100.05% | 136.77% | 145.03% | -- | 104.80% |
| Prepaid Expenses | -19.02% | -4.16% | -- | -- | 396.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 12.82% | 33.52% | 56.52% | -- | -- |
| Total Current Assets | 258.67% | 324.49% | 16.69% | -- | 34.61% |
|
|
|||||
| Total Current Assets | 258.67% | 324.49% | 16.69% | -- | 34.61% |
| Net Property, Plant & Equipment | 61.73% | 91.41% | 66.12% | -- | 62.34% |
| Long-term Investments | 1,897.53% | 2,264.11% | 2,027.14% | -- | -11.92% |
| Goodwill | 1,897.53% | 2,264.11% | 2,027.14% | -- | -11.92% |
| Total Other Intangibles | 168.06% | 217.25% | 430.09% | -- | 96.62% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 423.53% | 519.61% | 366.62% | -- | 390.92% |
| Total Assets | 239.12% | 301.36% | 140.96% | -- | 59.45% |
|
|
|||||
| Total Accounts Payable | 89.93% | 124.79% | -34.19% | -- | 95.96% |
| Total Accrued Expenses | 25.36% | 48.37% | 135.46% | -- | 51.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,151.21% | 1,380.82% | 345.27% | -- | 143.91% |
| Total Finance Division Other Current Liabilities | 98.71% | 135.18% | 108.59% | -- | 141.49% |
| Total Other Current Liabilities | 98.71% | 135.18% | 108.59% | -- | 141.49% |
| Total Current Liabilities | 82.00% | 115.40% | 81.60% | -- | 93.50% |
|
|
|||||
| Total Current Liabilities | 82.00% | 115.40% | 81.60% | -- | 93.50% |
| Long-Term Debt | 6,002.69% | 7,122.64% | 79.18% | -- | 148.58% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.73% | 13.94% | 26.15% | -- | 18.58% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -31.59% | -19.03% | -17.62% | -- | -4.58% |
| Total Liabilities | 234.90% | 296.36% | 46.33% | -- | 47.02% |
|
|
|||||
| Common Stock & APIC | 21.40% | 43.68% | 50.26% | -- | 20.65% |
| Retained Earnings | 26.67% | 13.22% | 17.93% | -- | 3.07% |
| Treasury Stock & Other | 596.88% | 688.06% | 263.94% | -- | -86.18% |
| Total Common Equity | 246.42% | 309.99% | 432.46% | 120.21% | 86.67% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 246.42% | 309.99% | 432.46% | 120.21% | 86.67% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 246.42% | 309.99% | 432.46% | 120.21% | 86.67% |
|
|
|||||
